National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.

Heart, lung & circulation

Volumn 14, Issue 4, 2005, Pages 275-291

  Tonkin, Andrew ^a   Barter, Philip ^a   Best, James ^a   Boyden, Andrew ^a   Furler, John ^a   Hossack, Ken ^a   Sullivan, David ^a   Thompson, Peter ^a   Vale, Margarite ^a   Cooper, Catherine ^a   Robinson, Malia ^a   Clune, Eleanor ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ARTICLE; AUSTRALIA; BLOOD; CARDIOVASCULAR DISEASE; HUMAN; LIFESTYLE; NEW ZEALAND; PRACTICE GUIDELINE; RISK ASSESSMENT;

APOLIPOPROTEINS; AUSTRALIA; CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIFE STYLE; NEW ZEALAND; PRACTICE GUIDELINES; RISK ASSESSMENT; TRIGLYCERIDES;

EID: 32644479927     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2005.10.010     Document Type: Note

References (0)